1. Curado MP, Johnson NW, Kerr AR, Silva DRM, Lanfranchi H, Pereira DR et al. Oral and oropharynx cancer in South America: incidence, mortality trends and gaps in public databases as presented to the global oral cancer forum. Translational Research in Oral Oncology. 2016;1:1-7.
https://doi.org/10.1177/2057178X16653761

2. Warnakulasuriya S. Global epidemiology of oral and oropharyngeal cancer. Oral Oncol. 2009;45:309-16.
https://doi.org/10.1016/j.oraloncology.2008.06.002
PMid:18804401

3. Van der Waal I. Oral leukoplakia, the ongoing discussion on definition and terminology. Med Oral Patol Oral Cir Bucal. 2015;20:685-92.
https://doi.org/10.4317/medoral.21007
PMid:26449439 PMCid:PMC4670248

4. Wang YP, Chen IC, Wu YH, Wu YC, Chen HM, Yu-Fong Chang J. Langerhans cell counts in oral epithelial dysplasia and their correlation to clinicopathological parameters. J Formos Med Assoc. 2017;116:457-63.
https://doi.org/10.1016/j.jfma.2017.02.006
PMid:28292622

5. Feller L, Lemmer J. Oral leukoplakia as It relates to HPV infection: a review. Int J Dent. 2012;2012:540561.
https://doi.org/10.1155/2012/540561
PMid:22505902 PMCid:PMC3299253

6. Angadi PV, Krishnapillai R. Evaluation of PTEN immunoexpression in oral submucous fibrosis: role in pathogenesis and malignant transformation. Head Neck Pathol. 2012;6:314-21.
https://doi.org/10.1007/s12105-012-0341-z
PMid:22392409 PMCid:PMC3422583

7. Gadbail AR, Chaudhary M, Gawande M, Hande A, Sarode S, Tekade AS, et al. Oral squamous cell carcinoma in the background of oral submucous fibrosis is a distinct clinicopathological entity with better prognosis. J Oral Pathol Med. 2017;46:448-53.
https://doi.org/10.1111/jop.12553
PMid:28129456

8. Arakeri G, Brennan PA. Oral submucous fibrosis: an overview of the etiology, pathogenesis, classification, and principles of management. Br J Oral Maxillofac Surg. 2013;51:587-93.
https://doi.org/10.1016/j.bjoms.2012.08.014
PMid:23107623

9. Chang MC, Lin LD, Wu HL, Ho YS, Hsien HC, Wang TM, et al. Areca nut- induced buccal mucosa fibroblast contraction and its signaling: a potential role in oral submucous fibrosis-a precancer condition. Carcinogenesis. 2013;34:1096-104.
https://doi.org/10.1093/carcin/bgt012
PMid:23349021

10. Sharma A, Kumar R, Johar N, Sabir H. Oral submucous fibrosis: an etiological dilemma. J Exp Ther Oncol. 2017;12:163-6.

11. Wang YC, Tsai YS, Huang JL, Lee KW, Kuo CC, Wang CS, et al. Arecoline arrests cells at prometaphase by deregulating mitotic spindle assembly and spindle assembly checkpoint: implication for carcinogenesis. Oral Oncol. 2010;46:255-62.
https://doi.org/10.1016/j.oraloncology.2010.01.003
PMid:20138568

12. Wang YP, Chen IC, Wu YH, Wu YC, Chen HM, Yu-Fong Chang J. Langerhans cell counts in oral epithelial dysplasia and their correlation to clinicopathological parameters. J Formos Med Assoc. 2017;116:457-63.
https://doi.org/10.1016/j.jfma.2017.02.006
PMid:28292622

13. Pellicioli ACA, Bingle L, Farthing P, Lopes MA, Martins MD, Vargas PA. Immunosurveillance profile of oral squamous cell carcinoma and oral epithelial dysplasia through dendritic and T-cell analysis. J Oral Pathol Med. 2017;46:928-33.
https://doi.org/10.1111/jop.12597
PMid:28585308

14. Gomes JO, Vasconcelos CM, Fonseca FP, Gondak RO, Lopes MA, Vargas PA. CD1a+ and CD83+ langerhans cells are reduced in lower lip squamous cell carcinoma. J Oral Pathol Med. 2016;45:433-9.
https://doi.org/10.1111/jop.12389
PMid:26661374

15. Costa NL, Gonçalves AS, Martins AF, Arantes DA, Silva TA, Batista AC. Characterization of dendritic cells in lip and oral cavity squamous cell carcinoma. J Oral Pathol Med. 2016;45:418-24.
https://doi.org/10.1111/jop.12380
PMid:26514660

16. Jardim JF, Gondak R, Galvis MM, Pinto CAL, Kowalski LP. A decreased peritumoral CD1a+ cell number predicts a worse prognosis in oral squamous cell carcinoma. Histopathology. 2018;72:905-13.
https://doi.org/10.1111/his.13415
PMid:29023924

17. Hovav AH. Dendritic cells of the oral mucosa. Mucosal Immunol. 2004;7:27-37.
https://doi.org/10.1038/mi.2013.42
PMid:23757304

18. Perez L, Shurin MR, Collins B, Kogan D, Tourkova IL, Shurin GV. Comparative analysis of CD1a, S-100, CD83, and CD11c human dendritic cells in normal, premalignant, and malignant tissues. Histopathology. 2005;20:1165-72.

19. Moschos S, Varanasi S, Kirkwood JM. Interferons in the treatment of solid tumors. Cancer Treat Res. 2005;126:207-41.
https://doi.org/10.1007/0-387-24361-5_9
PMid:16209068

20. Zitvogel L, Galluzzi L, Kepp O, Smyth MJ, Kroemer G. Type I interferons in anticancer immunity. Nat Rev Immunol. 2015;15:405-14.
https://doi.org/10.1038/nri3845
PMid:26027717

21. Souto GR, Matias MDP, Nunes LFM, Ferreira RC, Mesquita RA. Mature dendritic cell density is affected by smoking habit, lesion size, and epithelial dysplasia in oral leukoplakia samples. Arch Oral Biol. 2018;95:51-7.
https://doi.org/10.1016/j.archoralbio.2018.07.008
PMid:30056280

22. Gondak RO, Alves DB, Silva LF, Mauad T, Vargas PA. Depletion of langerhans cells in the tongue from patients with advanced-stage acquired immune deficiency syndrome: relation to opportunistic infections. Histopathology. 2012;60:497-503.
https://doi.org/10.1111/j.1365-2559.2011.04068.x
PMid:22168427

23. Arakeri G, Boraks G, Aljabab AS, Patil SG, Merkx MA, Brennan PA. Breath alkane as an index of severity for oral submucous fibrosis: a new perspective?. Med Hypothese. 2017;98:18-20.
https://doi.org/10.1016/j.mehy.2016.11.005
PMid:28012596

24. Idoyaga J, Cheong C, Suda K, Suda N, Kim JY, Lee H, et al. Cutting edge: langerin/CD207 receptor on dendritic cells mediates efficient antigen presentation on MHC I and II products in vivo. J Immunol. 2018;180:3647-50.
https://doi.org/10.4049/jimmunol.180.6.3647
PMid:18322168